Hyperinsulinism
Gene: CACNA1D
1 patient with congential hyperinsulinemic hypoglycemia and primary hyperaldosteronism, aortic insufficiency, pronounced developmental delay, muscle hypotonia, and facial dysmorphias but without seizures. Trio WES identified a de novo CACNA1D missense variant (p.L271H). No functional work.Created: 14 May 2024, 4:55 a.m. | Last Modified: 14 May 2024, 4:55 a.m.
Panel Version: 1.11
Phenotypes
congenital hyperinsulinism, primary hyperaldosteronism, and neurologic abnormalities
Publications
GoF de novo variant reported in infant with persistent hyperinsulinaemia, congenital heart disease and hypotonia. Same variant reported in another individual with some overlapping features and transient hypoglycaemia in the newborn period; however, hyperinsulinaemia not confirmed in this other individual.
Sources: Expert listCreated: 14 Feb 2020, 5:25 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Hyperinsulinism; heart defect; hypotonia
Publications
Mode of pathogenicity
Other
Gene: cacna1d has been classified as Amber List (Moderate Evidence).
Gene: cacna1d has been classified as Red List (Low Evidence).
gene: CACNA1D was added gene: CACNA1D was added to Hyperinsulinism. Sources: Expert list Mode of inheritance for gene: CACNA1D was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: CACNA1D were set to 28318089; 23913001 Phenotypes for gene: CACNA1D were set to Hyperinsulinism; heart defect; hypotonia Mode of pathogenicity for gene: CACNA1D was set to Other Review for gene: CACNA1D was set to RED